Search
for
Sort by
Research 151–180 of 430
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Targets to treat androgen excess in polycystic ovary syndrome
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Hirsutism and virilization
- Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging
- Sulforaphane promotes murine hair growth by accelerating the degradation of dihydrotestosterone
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Alopecia - the search for novel agents continues
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Dermatosis associated with menopause
- Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
- Uso de la espironolactona en dermatología: acné, hidradenitis supurativa, alopecia femenina e hirsutismo
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Treatment of hyperandrogenism in women
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Post-finasteride syndrome – does it really exist?
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Spironolactone May Reduce the Risk of Incident Rosacea
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- The role of androgens in hormone replacement therapy
- Endocrine disorders and hormonal therapy for adolescent acne
- PCOS and Obesity: Contraception Challenges
- Acne